Mutational analysis and clinical correlation of metastatic colorectal cancer. - Wikidata - awgldk - TriplyDB

Mutational analysis and clinical correlation of metastatic colorectal cancer.

Mutational analysis and clinical correlation of metastatic colorectal cancer.

http://www.wikidata.org/entity/Q35082873

about

Impact of somatic mutations on patterns of metastasis in colorectal cancer RAS and BRAF in metastatic colorectal cancer management PI3K pathway mutations are associated with longer time to local progression after radioembolization of colorectal liver metastases.DNA methylation epigenotype and clinical features of NRAS-mutation(+) colorectal cancer Predictive model for high-frequency microsatellite instability in colorectal cancer patients over 50 years of age.Current approaches for predicting a lack of response to anti-EGFR therapy in KRAS wild-type patients Correlation of extended RAS and PIK3CA gene mutation status with outcomes from the phase III AGITG MAX STUDY involving capecitabine alone or in combination with bevacizumab plus or minus mitomycin C in advanced colorectal cancer High BRAF Mutation Frequency and Marked Survival Differences in Subgroups According to KRAS/BRAF Mutation Status and Tumor Tissue Availability in a Prospective Population-Based Metastatic Colorectal Cancer Cohort.LINE-1 hypomethylation in normal colon mucosa is associated with poor survival in Chinese patients with sporadic colon cancer.Impact of RAS and BRAF mutations on carcinoembryonic antigen production and pattern of colorectal metastases Identification of T-cell Receptors Targeting KRAS-Mutated Human Tumors.Mutation profiling in chinese patients with metastatic colorectal cancer and its correlation with clinicopathological features and anti-EGFR treatment response.(18)F-FDG PET/CT imaging in rectal cancer: relationship with the RAS mutational status.Review on adjuvant chemotherapy for rectal cancer - why do treatment guidelines differ so much?Pattern and Dynamics of Distant Metastases in Metastatic Colorectal Cancer.Segmental distribution of some common molecular markers for colorectal cancer (CRC): influencing factors and potential implications.Clinical significance of circulating plasma DNA in gastric cancer.mRNA expression profiles in circulating tumor cells of metastatic colorectal cancer patients.Comparative molecular analyses of left-sided colon, right-sided colon, and rectal cancers.LRF inhibits p53 expression in colon cancer cells via modulating DAP5 activity.Mutation Spectra of Common Cancer-Associated Genes in Different Phenotypes of Colorectal Carcinoma Without Distant Metastasis.Clinical relevance of alterations in quantity and quality of plasma DNA in colorectal cancer patients: based on the mutation spectra detected in primary tumors.Deficient mismatch repair and RAS mutation in colorectal carcinoma patients: a retrospective study in Eastern China.Mutations of key driver genes in colorectal cancer progression and metastasis.Oncogene mutation profile predicts tumor regression and survival in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy and radical surgery.Frequency of NRAS Gene Mutation in Wild Type KRAS and BRAF Colorectal Cancers; a Single Center Study.Predictive and Prognostic Implications of Mutation Profiling and Microsatellite Instability Status in Patients with Metastatic Colorectal Carcinoma.Upregulation of c-mesenchymal epithelial transition expression and RAS mutations are associated with late lung metastasis and poor prognosis in colorectal carcinoma.

P2860

Q26772279-C14EFCF2-96A2-4C29-8289-ED6C248562D5 Q28074175-8226CC25-471B-46EA-BC28-3C03F6F22320 Q33618754-D6E06958-8F49-4FC6-9C14-318C0E621105 Q33679684-DBD44978-E50D-42D6-A5D3-FBAB5D73C873 Q33775336-6567A053-C828-4E1B-8E94-4482D7846711 Q33861210-1801208C-47DC-4436-852D-07313DDDFE34 Q35198335-FA82C60F-8306-468A-8406-71207EF4FAFA Q35677169-455DA380-6A3F-4E2C-AF37-8262E26DFB4A Q36414307-6E95102E-24B5-49CE-B44A-779BFB7D91B0 Q36465989-0861E22C-496F-471D-9AB4-FB6CEFD072EE Q36643027-54FAEE50-C9B9-4C8B-940B-A0EFC30EB046 Q37317549-C396BC9A-25D6-4E40-BBEF-126524BBB413 Q37600941-36E0D780-10E2-483A-A61D-4BC7C7F03717 Q38322257-213D40FB-F6BF-4820-9663-30C1D00AD215 Q38671275-FB0FE028-8E29-4566-A65B-AF8A57360C8C Q38722180-18885383-46AC-4762-82A7-5B7C129624DD Q40948643-BF74A091-CD7F-4D82-9D59-7D9CBA4C5B1F Q41136311-820C8628-D62F-4296-B9B4-6B5E6A76850D Q46185591-4B26EEBE-8633-4392-8B94-7D2EBEAE84FA Q47889968-42A4E97A-3A80-47AF-914A-A70CE564954A Q48072505-F2F0CD20-7374-4C6C-A1E9-ECD0299BF298 Q48292008-93297AAB-5CCD-41F4-809D-3EB551AA3F21 Q49307611-5AFC855F-FC67-45CA-B309-030E0D14EDB2 Q50097873-CE1E9D20-656B-4F8F-9E49-584F2C5CAAF8 Q50549156-83DFEA38-A049-482F-B0D4-77F54F19A742 Q54949200-3931300C-0CCD-447F-AC4F-027AAEAB3E5A Q55028937-03C2E663-E336-4D42-8BE8-38B2D57ED875 Q55408333-660CCECA-6500-4FFA-9811-1ABD84C5B407

P2860

Mutational analysis and clinical correlation of metastatic colorectal cancer.

http://www.wikidata.org/entity/Q35082873

description

2014 nî lūn-bûn

@nan

2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Mutational analysis and clinical correlation of metastatic colorectal cancer.

@ast

Mutational analysis and clinical correlation of metastatic colorectal cancer.

@en

type

label

Mutational analysis and clinical correlation of metastatic colorectal cancer.

@ast

Mutational analysis and clinical correlation of metastatic colorectal cancer.

@en

prefLabel

Mutational analysis and clinical correlation of metastatic colorectal cancer.

@ast

Mutational analysis and clinical correlation of metastatic colorectal cancer.

@en

P1433

Q35082873-7698B9E6-BB5A-41EE-9172-4AAD31A8A263

P1476

Q35082873-FA7773E0-3415-44B1-9566-334B21B537D7

P2093

Q35082873-0BDAD3BF-EEA1-4306-9CDD-D7B86E2D2C58

Q35082873-136FAC6E-1B38-48EC-8FB6-FF7B7BDA27C2

Q35082873-14E25E91-B740-4266-9F46-2626ED49C010

Q35082873-16C0BC04-8147-4670-A82D-6BC09CD902A5

Q35082873-382A9F18-BD82-4C50-9911-FAB1FF1F6C2A

Q35082873-764CE1D8-6D72-477E-BCF2-B315A395637C

Q35082873-7F3B3E45-88C9-4CD8-9131-079705AA1DB6

Q35082873-9104B083-A0B5-44DB-9053-62577A7F1961

Q35082873-AE21FD8D-5FEA-4179-8AEB-6919E726CEED

Q35082873-B1B9CE2B-8CCF-452C-9B32-96F643495638

P2860

Q35082873-2B831AB1-B452-43A7-AD75-BF338C6F12D5

Q35082873-2CEEBDE3-9EF5-49C5-B08E-5E6DB20FB53C

Q35082873-35358FF2-9EF0-4110-AA3E-1B61ED4967BE

Q35082873-392E8247-1578-42FC-A8E0-F71304817BD1

Q35082873-45708927-351E-4836-9D05-E5C4975139C0

Q35082873-48026605-84E7-4A3C-96C7-FE881A93D6B6

Q35082873-4BB5C3D3-F305-48A7-9F79-6989B4DBE19E

Q35082873-599E81EF-A686-4DDA-B1E3-77D3007F0444

Q35082873-6AAE374E-0FAC-464E-9240-E223DF2302A3

Q35082873-6F5044B9-10E8-4023-A083-E074AA8632EA

P304

Q35082873-C36685ED-35C7-4F02-80BE-C205BAA7DA01

P31

Q35082873-ACE45F0E-42D0-4A19-A57E-D207A3B9CDC8

P356

Q35082873-88E3DDE2-3719-4740-BD79-3BAA1325892C

P407

Q35082873-F1356B0E-FD4D-47FB-9D26-659095D5339B

P433

Q35082873-CDF24156-E75D-46FA-8C4B-B6247BB45C04

P478

Q35082873-EC32F7BA-5C8D-4BB6-9ED1-37472F3E17D3

P577

Q35082873-A3867BE0-64AE-4983-A8DA-C9F56D46D91B

P5875

Q35082873-B1E4EF2C-06C4-46D8-B02C-EF3A6EDA112E

P698

Q35082873-4ABD8DCD-D1A0-4B38-AC21-3CAA415C52EA

P921

Q35082873-715535FA-DBF4-4394-8E7D-7B5B6A8C5B0A

P932

Q35082873-A1AE502F-69DF-4429-AB24-3DDF5B25C4EF

P356

P1433

P1476

Mutational analysis and clinical correlation of metastatic colorectal cancer.

@en

P2093

Andrea L Russo

http://www.w3.org/2001/XMLSchema#string

Andrew X Zhu

http://www.w3.org/2001/XMLSchema#string

Anthony J Iafrate

http://www.w3.org/2001/XMLSchema#string

Darrell R Borger

http://www.w3.org/2001/XMLSchema#string

David P Ryan

http://www.w3.org/2001/XMLSchema#string

Dora Dias-Santagata

http://www.w3.org/2001/XMLSchema#string

Eunice L Kwak

http://www.w3.org/2001/XMLSchema#string

Jackie Szymonifka

http://www.w3.org/2001/XMLSchema#string

Janet E Murphy

http://www.w3.org/2001/XMLSchema#string

Jason E Faris

http://www.w3.org/2001/XMLSchema#string

P2860

Comprehensive molecular characterization of human colon and rectal cancer

A genetic model for colorectal tumorigenesis

Biology of the adenomatous polyposis coli tumor suppressor

DNA sequence profiles of the colorectal cancer critical gene set KRAS-BRAF-PIK3CA-PTEN-TP53 related to age at disease onset.

BRAF V600E mutations are common in pleomorphic xanthoastrocytoma: diagnostic and therapeutic implications.

NRAS mutations are rare in colorectal cancer.

The prognostic value of BRAF mutation in colorectal cancer and melanoma: a systematic review and meta-analysis.

The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment.

BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancer

TP53 mutation in colorectal cancer.

P304

1482-1490

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.28599

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

120

http://www.w3.org/2001/XMLSchema#string

P577

2014-02-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260117296

http://www.w3.org/2001/XMLSchema#string

P698

24500602

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

4327902

http://www.w3.org/2001/XMLSchema#string